iRadimed
IRMD
126 hedge funds and large institutions have $295M invested in iRadimed in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 55 increasing their positions, 34 reducing their positions, and 17 closing their positions.
217% more call options, than puts
Call options by funds: $361K | Put options by funds: $114K
62% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 34
47% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 17
6% more funds holding
Funds holding: 119 → 126 (+7)
1.25% more ownership
Funds ownership: 51.8% → 53.05% (+1.3%)
5% less capital invested
Capital invested by funds: $310M → $295M (-$14.7M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
+$18.4M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$4.56M |
| 3 |
IP
Isthmus Partners
Madison,
Wisconsin
|
+$2.85M |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$2.33M |
| 5 |
RC
Roubaix Capital
Denver,
Colorado
|
+$2.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$12.4M |
| 2 |
Morgan Stanley
New York
|
-$4.33M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$1.96M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$1.86M |
| 5 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$1.82M |
IRMD Hedge Fund Activity: Q1 2024 in Review
126 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q1 2024, worth a combined $295M — down 4.7% from $310M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new IRMD positions and 17 closed out — a net gain of 8 holders — while 55 added to existing stakes and 34 trimmed.
The largest buyer was Copeland Capital Management, adding an estimated $18.4M. The largest seller was Soleus Capital Management, cutting an estimated $12.4M.
- 126 institutional investors held iRadimed (IRMD) as of Q1 2024, up from 119 in Q4 2023.
- Funds reported $295M of iRadimed stock for Q1 2024, down 4.7% quarter-over-quarter.
- 25 funds opened new iRadimed positions in Q1 2024 and 17 closed out, a net change of +8 holders.
- The largest iRadimed buyer in Q1 2024 was Copeland Capital Management, an estimated $18.4M added.
- The largest iRadimed seller in Q1 2024 was Soleus Capital Management, an estimated $12.4M sold.
Based on aggregated 13F filings for Q1 2024.